magnesium sulfate; polyethylene glycol 3350; potassium chloride; potassium sulfate; sodium bicarbonate; sodium chloride; sodium sulfate
Drug data last refreshed 3h ago · AI intelligence enriched Yesterday
SUCLEAR is an oral solution bowel prep agent containing polyethylene glycol 3350 combined with electrolytes (magnesium sulfate, potassium chloride, potassium sulfate, sodium bicarbonate, sodium chloride, sodium sulfate). It is used to cleanse the colon prior to colonoscopy or other GI procedures. The formulation works by osmotic laxative action, drawing water into the bowel to facilitate complete evacuation.
Product is at peak lifecycle stage with moderate competitive pressure (30), suggesting stable but mature market dynamics favoring experienced brand management and field execution teams.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on SUCLEAR offers stable career positioning in a mature, procedurally-driven market with established patient populations and reimbursement patterns. Roles emphasize commercial execution, relationship management with GI centers and hospitals, and competitive differentiation in a moderately contested segment.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo